Articles
Perspectives on CME: part 3 - the patient in CME

Perspectives on CME: part 3 - the patient in CME

In the third part of our interview series with Lawrence Sherman we learn what the role of the patient is within CME. Previously in this interview series we’ve heard how CME can be of value and what role pharma has to play in providing education...

Articles
Social pharma faces: Ed Bennett

Social pharma faces: Ed Bennett

Ed Bennett has journeyed from being a fire juggler to the director of web strategy at the University of Maryland Medical Centre. Here he describes this path and shares his thoughts on social media in the healthcare industry. In the latest in our social pharma faces series we’re stepping away from individuals in the pharma industry and onto a well known...

Articles
Direct to patient distribution – helping brands fight against generics

Direct to patient distribution – helping brands fight agains...

Hardik Singhvi looks at the benefits to pharmaceutical companies of ‘direct to patient’ product distribution, compared with the previous model, ‘direct to pharmacy’. Over the years, pharmaceutical companies have been selling their products through pre-wholesalers and regional wholesalers, because...

Sales & Marketing

Digital

Market Access

Editor's Picks

  1. ESMO26: Tango sees 82% ORR with combo in pancreatic cancer
  2. Roche offers $15bn for strategic-level deal with Hansoh
  3. ESMO26: Moderna, MSD reveal cancer jab data early after leak
  4. Clinical trial setup times fall sharply in UK
  5. Despite US policy changes, drug prices stay stubbornly high

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more